Arcutis Biotherapeutics, Inc. (ARQT) — Financial ratios
Profitability, liquidity, leverage, and valuation ratios for Arcutis Biotherapeutics, Inc., with annual and quarterly history.
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|
| Valuation | ||||||
| P/E Ratio | -228.91x | -12.03x | -0.85x | -2.62x | -4.97x | -7.40x |
| P/B Ratio | 19.50x | 10.70x | 2.52x | 3.89x | 3.44x | 3.71x |
| P/S Ratio | 9.82x | 8.57x | 3.76x | 220.96x | 0.00x | 0.00x |
| Profitability | ||||||
| Gross Margin | 90.2% | 90.3% | 91.6% | 79.5% | 0.0% | 0.0% |
| Operating Margin | -3.3% | -65.3% | -404.5% | -8183.0% | 0.0% | 0.0% |
| Net Margin | -4.3% | -71.3% | -439.8% | -8449.8% | 0.0% | 0.0% |
| EBITDA Margin | 0.7% | -55.8% | -381.6% | -7991.1% | 0.0% | 0.0% |
| Liquidity | ||||||
| Current Ratio | 3.17x | 4.15x | 7.08x | 11.57x | 12.09x | 12.96x |
| Quick Ratio | 2.99x | 3.97x | 6.80x | 11.37x | 12.09x | 12.96x |
| Leverage | ||||||
| Debt/Equity | 0.03x | 0.70x | 2.32x | 0.97x | 0.26x | 0.02x |
YoY = year-over-year change. Source: FMP..